In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

Objective: Ciprofloxacin resistance (CIP(R)) for Shigella isolates is becoming more prevalent. This study systematically investigated the antibacterial activity of ciprofloxacin (CIP)/fosfomycin (FOS) combination in vitro and in vivo against CIP(R) S. flexneri isolates. Method: Eighty CIP(R) S. flex...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanyan, Li, Hongru, Zhang, Yalong, Ye, Ying, Gao, Yufeng, Li, Jiabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580129/
https://www.ncbi.nlm.nih.gov/pubmed/31354311
http://dx.doi.org/10.2147/IDR.S208071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580129/
https://www.ncbi.nlm.nih.gov/pubmed/31354311
http://dx.doi.org/10.2147/IDR.S208071

Ejemplares similares